I came to the same conclusion about the break even on 5,000 scripts a month. The cost of sales is more than the receipts from income before taking into account anything else.
The unknowns from the cash flow report are:
1. Payment terms of customers, and how much is outstanding.
2. What other expenses are they not paying? I have a hunch that their unpaid creditors will be huge. Always is in distressed companies and it does not show on the cashflow statement. Looks like they are paying for what they have to for materials and not much else.
Ann: UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINES, page-15
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.015(4.48%) |
Mkt cap ! $16.94M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.5¢ | 33.0¢ | $60.95K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11855 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 1338 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |